(Q44248031)

1 December 2017

Effect of the addition of montelukast to inhaled fluticasone propionate on airway inflammation (English)

1 reference

1 December 2017

0 references

fluticasone propionate

1 reference

1

Siobhán O'Sullivan

1 reference

1 December 2017

Martijn Akveld

2

1 reference

1 December 2017

Conor M Burke

series ordinal

3

1 reference

1 December 2017

Leonard W Poulter

series ordinal

4

1 reference

1 December 2017

language of work or name

English

0 references

publication date

12 December 2002

1 reference

American Journal of Respiratory and Critical Care Medicine

1 December 2017

1 reference

1 December 2017

167

1 reference

1 December 2017

5

1 reference

1 December 2017

745-750

1 reference

Airway inflammation in mild intermittent and in persistent asthma.

1 December 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Airway hyperresponsiveness to cigarette smoke in ovalbumin-sensitized guinea pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Relative effects of inhaled corticosteroids on immunopathology and physiology in asthma: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Repeatability of measures of inflammatory cell number in bronchial biopsies in atopic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Effects of varying doses of fluticasone propionate on the physiology and bronchial wall immunopathology in mild-to-moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Effects of adding either a leukotriene receptor antagonist or low-dose theophylline to a low or medium dose of inhaled corticosteroid in patients with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Comparison of montelukast versus budesonide in the treatment of exercise-induced bronchoconstriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

NO in Exhaled Air of Asthmatic Children Is Reduced by the Leukotriene Receptor Antagonist Montelukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

21 January 2018

A case of garlic allergy

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? No

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Interleukin-5-producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Leukotriene E4 and granulocytic infiltration into asthmatic airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Effect of pranlukast on bronchial inflammation in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

The relationship between airways inflammation and asthma severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

Additive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-783OC

10.1164/RCCM.200208-783OC

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference